Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chikanza

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|October 18, 2006
The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritisD L Kozaci, Y Chernajovsky, I C Chikanza
The Journal of Rheumatology|April 1, 1995
Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritisI C Chikanza, G Kingsley, G S Panayi
Nature Clinical Practice. Rheumatology|November 30, 2006
Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosisLazaros I Sakkas, Ian C Chikanza, Chris D Platsoucas
The Journal of Rheumatology|November 1, 1994
The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patientsI C Chikanza, M Stein, S Lutalo, et al.
Journal of Immunological Methods|October 2, 1992
Enumeration of interleukin-1 alpha and beta producing cells by flow cytometryI C Chikanza, V Corrigal, G Kingsley, et al.
The Journal of Pharmacy and Pharmacology|June 13, 1998
Why do we need new treatments for rheumatoid arthritis?I C Chikanza, S Jawed, D Naughton, et al.
Clinical Rheumatology|July 4, 2025
CAR-T cells in systemic sclerosisLazaros I Sakkas, Chistina Katsiari, Vasiliki Syrmou, et al.
Clinical Rheumatology|April 5, 2026
Regulatory T cells as a potential treatment for autoimmune inflammatory rheumatic and musculoskeletal diseasesIan C Chikanza, Clementine Sifiso Nomalizo Mnkandla-Khumalo, Lazaros I Sakkas
British Journal of Rheumatology|June 1, 1993
Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implicationsI C Chikanza, P Petrou, G Chrousos, et al.
Arthritis and Rheumatism|May 1, 1995
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implicationsI C Chikanza, P Roux-Lombard, J M Dayer, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|October 18, 2006
The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritisD L Kozaci, Y Chernajovsky, I C Chikanza
The Journal of Rheumatology|April 1, 1995
Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritisI C Chikanza, G Kingsley, G S Panayi
Nature Clinical Practice. Rheumatology|November 30, 2006
Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosisLazaros I Sakkas, Ian C Chikanza, Chris D Platsoucas
The Journal of Rheumatology|November 1, 1994
The clinical, serologic and radiologic features of rheumatoid arthritis in ethnic black Zimbabwean and British Caucasian patientsI C Chikanza, M Stein, S Lutalo, et al.
Journal of Immunological Methods|October 2, 1992
Enumeration of interleukin-1 alpha and beta producing cells by flow cytometryI C Chikanza, V Corrigal, G Kingsley, et al.
The Journal of Pharmacy and Pharmacology|June 13, 1998
Why do we need new treatments for rheumatoid arthritis?I C Chikanza, S Jawed, D Naughton, et al.
Clinical Rheumatology|July 4, 2025
CAR-T cells in systemic sclerosisLazaros I Sakkas, Chistina Katsiari, Vasiliki Syrmou, et al.
Clinical Rheumatology|April 5, 2026
Regulatory T cells as a potential treatment for autoimmune inflammatory rheumatic and musculoskeletal diseasesIan C Chikanza, Clementine Sifiso Nomalizo Mnkandla-Khumalo, Lazaros I Sakkas
British Journal of Rheumatology|June 1, 1993
Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implicationsI C Chikanza, P Petrou, G Chrousos, et al.
Arthritis and Rheumatism|May 1, 1995
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implicationsI C Chikanza, P Roux-Lombard, J M Dayer, et al.
Pageof 5